Clopidogrel Superior to 'Divine' Aspirin Monotherapy in Secondary Prevention

P2Y12 inhibitors reduced the risk of MI by 19%, and researchers say it’s time to move beyond aspirin for long-term use.

Related Keywords

Italy ,Milan ,Lombardia ,Caprie ,Piemonte ,South Korea ,Arman Qamar ,Northshore University Health System ,Astrazeneca ,Phd Humanitas University ,Humanitas University ,European Heart Journal ,